Discover how MSPs can streamline Microsoft 365 management. This session breaks down smarter security, automation, and cost control—helping you scale services and manage customers with confidence.

RIGHT JOIN (or RIGHT OUTER JOIN): It’s the opposite of a LEFT JOIN. It keeps all rows from the right table and matches from the left. Less common than LEFT JOIN, but good to know it exists.

Eli Lilly has penned a research pact worth $1.2 billion in biobucks with SanegeneBio to help pinpoint cardiometabolic RNAi medicines at the correct tissues. The agreement centers around Sanegene’s ...

Artificial intelligence giant OpenAI Group PBC is reportedly laying the ground work for an initial public offering that could value the company at $1 trillion. Reuters, refering to three people ...

Pew Research Center conducted this study to understand Americans’ views of artificial intelligence (AI) and its potential impact on people and society. For this analysis, we surveyed 5,023 adults from ...

Men and women view career ambition in a potential partner very differently, according to a new report from dating app The League. While women said career ambition matters when deciding to match with ...

Autonomous aviation startup Merlin Labs will soon be soaring into the public markets now that it has signed a deal to merge with a blank-check company early next year. The terms of the deal, with a ...

Cameron Heyward wants a raise. And the longtime Pittsburgh Steelers defensive tackle is open to sitting out regular-season games to get one. Heyward told reporters Monday that he approached the club ...

The UFC will get rid of its pay-per-view model as part of its massive $7.7 billion agreement to air its events on Paramount+ starting in 2026, its parent company TKO announced on Monday. The ...

A faceoff between the Pittsburgh Steelers and their star defensive tackle is brewing. On Monday, All-Pro tackle Cam Heyward confirmed reports of a hold-in, telling reporters that he was looking for a ...

Thermo Fisher has good growth prospects ahead. Core pharma, biotech, and bioproduction businesses are driving growth, with US manufacturing investments and the Solventum acquisition strengthening ...